Guernsey's law expertise has facilitated the establishment
in the island of a US medical and wellness firm to enable the
acquisition of Europe's largest vertically integrated medical
cannabis company.
Curaleaf International Holding Limited acquired EMMAC Life
Sciences Limited at an implied post money valuation of $413m.
Curaleaf was assisted by Collas Crill's advisory team in
Guernsey, led by Paul Wilkes and Senior Associate Gareth Morgan.
The law firm's role included advising on the establishment in
Guernsey of Curaleaf International to hold the EMMAC investment,
and further its European expansion.
Mr Wilkes said: "It was a pleasure to work with the
Curaleaf and broader transaction team to get this transaction over
the line, notwithstanding a challenging timeline and some complex
elements. Well done to all, in particular Gareth's coordination
and leadership as we neared the finish line."
